Next99

Next99 is a communication and technology company specializing in healthcare, with a focus on digital therapeutics (DTx), medical market research, and healthcare marketing. Founded on September 19, 2019, the company aims to build applications that assist health startups and companies in improving patient lives. Next99 positions itself as a partner for purpose-driven startups, offering expertise, creativity, and innovation to help them overcome challenges related to capital limitations and navigate the complexities of the health and wellness industries. Their mission is to make workflow automation possible for every digital health company, empowering the health economy workforce to be more productive so patients can receive care more rapidly. The company emphasizes building the next-generation architecture for deploying media and web applications quickly.

Next99's approach involves cross-pollinating deep tech, regulatory frameworks, market research, and media to advance health. Their team comprises a diverse group of professionals including engineers, designers, data scientists, publishers, product managers, clinicians, scientists, strategists, and experts in privacy and regulation. This team collaborates to build, test, and validate digital health applications. The company highlights its experience with a dataset of 12,000 digital health projects and the completion of 35 such initiatives. They offer a range of services including UX and UI design, software development, discovery and product planning, debugging, and branding. Next99 states they are proficient in various technologies, including Python, Ruby, JavaScript, and frameworks like React and Angular, as well as mobile development with Swift and Java. They also work with legacy code. The company operates on a 100% remote work model, with team members located in places like Chennai, Miami, and Manchester. They emphasize that nothing is off-shored or outsourced, with direct oversight on all projects. Next99 adheres to healthcare standards such as HIPAA, HITECH, HL7, FHIR, and C-CDA.